Gain Therapeutics (GANX) Capital Expenditures (2020 - 2024)
Gain Therapeutics (GANX) recorded Capital Expenditures of $945.00 in Q4 2024, compared with $19.00 a year earlier.
Powered by 
Analysis
Gain Therapeutics (GANX) Capital Expenditures (2020 - 2024) Analysis & Trends
For FY2024, Gain Therapeutics reported Capital Expenditures of $22,493, up 46.5% from FY2023.
- Annual Capital Expenditures has a four-year compound annual growth rate of 1.9% (FY2020 to FY2024).
- Across earlier years, Capital Expenditures came in at $15,358 in FY2023 (-87.1%), $118,953 in FY2022 (+26.3%), $94,212 in FY2021 (+352.4%) and $20,826 in FY2020.
- The Q4 2024 figure is the highest quarterly Capital Expenditures since Q2 2023.
- On a year-over-year basis, Capital Expenditures rose in 1 of the last five quarters, with an average decline of 69.8%.
- Peak year-over-year performance for Capital Expenditures in the last five years was growth of 481.7% in Q1 2021, against a decline of 99.8% in Q3 2024 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.50 Bn | 1,103.09 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 616.20 Bn | 534.73 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 500.82 Bn | 473.93 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 367.31 Bn | 321.69 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 297.77 Bn | 261.76 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 261.35 Bn | 235.04 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 235.40 Bn | 190.80 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 190.59 Bn | 164.79 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 169.39 Bn | 116.04 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Gain Therapeutics | 51.03 Mn | -8.26 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 945.00 |
| Sep 30, 2024 | 1.00 |
| Dec 31, 2023 | 19.00 |
| Sep 30, 2023 | 650.00 |
| Jun 30, 2023 | 3,644.00 |
| Mar 31, 2023 | 11,045.00 |
| Dec 31, 2022 | 9,398.00 |
| Sep 30, 2022 | 57,179.00 |
| Jun 30, 2022 | 44,551.00 |
| Mar 31, 2022 | 7,825.00 |
| Dec 31, 2021 | 11,098.00 |
| Sep 30, 2021 | 32,123.00 |
| Jun 30, 2021 | 22,503.00 |
| Mar 31, 2021 | 28,488.00 |
| Dec 31, 2020 | 14,551.00 |
| Sep 30, 2020 | 1,416.00 |
| Jun 30, 2020 | -38.00 |
| Mar 31, 2020 | 4,897.00 |
API Access
Gain Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=GANX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "GANX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=GANX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();